Gastrointestinal microbes interact with canine adipose-derived mesenchymal stem cells in vitro and enhance immunomodulatory functions

Stem Cells and Development

Volumn 23, Issue 16, 2014, Pages 1831-1843

  Kol, Amir ^a   Foutouhi, Soraya ^a   Walker, Naomi J ^a   Kong, Nguyet T ^a   Weimer, Bart C ^a   Borjesson, Dori L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; CYCLOOXYGENASE 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROBIOTIC AGENT; PROSTAGLANDIN E2; CYTOKINE;

ADIPOSE DERIVED STEM CELL; ANIMAL CELL; ARTICLE; BACTERIUM; CELL DEATH; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL STRUCTURE; CELL VIABILITY; COMMENSAL; CROHN DISEASE; CYTOKINE RELEASE; GENETIC TRANSCRIPTION; IMMUNOMODULATION; IN VITRO STUDY; INTESTINE FLORA; LACTOBACILLUS ACIDOPHILUS; LYMPHOCYTE PROLIFERATION; MESENCHYMAL STEM CELL; MICROBIAL COMMUNITY; MICROORGANISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SALMONELLA TYPHIMURIUM; SEPSIS; T LYMPHOCYTE; UPREGULATION; WOUND HEALING IMPAIRMENT; ANIMAL; BACTERIUM ADHERENCE; CELL CULTURE; CELL MOTION; CELL SURVIVAL; DOG; GASTROINTESTINAL TRACT; GENETICS; HOST PATHOGEN INTERACTION; IMMUNOLOGY; MESENCHYMAL STROMA CELL; METABOLISM; MICROBIOLOGY; PHYSIOLOGY; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHIMURIUM; SECRETION (PROCESS); TRANSCRIPTION INITIATION;

ANIMALS; BACTERIAL ADHESION; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; DOGS; GASTROINTESTINAL TRACT; HOST-PATHOGEN INTERACTIONS; IMMUNOMODULATION; MESENCHYMAL STROMAL CELLS; SALMONELLA TYPHIMURIUM; T-LYMPHOCYTES; TRANSCRIPTIONAL ACTIVATION;

EID: 84905656202     PISSN: 15473287     EISSN: 15578534     Source Type: Journal    
DOI: 10.1089/scd.2014.0128     Document Type: Article

References (69)

1. Singer NG and AI Caplan. (2011). Mesenchymal stem cells: mechanisms of inflammation. Annu Rev Pathol 6:457-478.
2. Carrade DD, MW Lame, MS Kent, KC Clark, NJ Walker and DL Borjesson. (2012). Comparative analysis of the immunomodulatory properties of equine adult-derived mesenchymal stem cells. Cell Med 4:1-11.
3. Soleymaninejadian E, K Pramanik and E Samadian. (2012). Immunomodulatory properties of mesenchymal stem cells: cytokines and factors. Am J Reprod Immunol 67:1-8.
4. Ghannam S, J Pene, G Torcy-Moquet, C Jorgensen and H Yssel. (2010). Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype. J Immunol 185:302-312.
5. US National Institute of Health. Mesenchymal stem cells clinical trials. Available at: http://clinicaltrials.gov/ct2/results?term = mesenchymal + stem + cell. (Accessed 8th August 2014).
6. He XW, XS He, L Lian, XJ Wu and P Lan. (2012). Systemic infusion of bone marrow-derived mesenchymal stem cells for treatment of experimental colitis in mice. Dig Dis Sci 57:3136-3144.
7. Tanaka F, K Tominaga, M Ochi, T Tanigawa, T Watanabe, Y Fujiwara, K Ohta, N Oshitani, K Higuchi and T Arakawa. (2008). Exogenous administration of mesenchymal stem cells ameliorates dextran sulfate sodium-induced colitis via anti-inflammatory action in damaged tissue in rats. Life Sci 83:771-779.
8. Wood JA, DJ Chung, SA Park, AL Zwingenberger, CM Reilly, I Ly, NJWalker, W Vernau, K Hayashi, et al. (2012). Periocular and intra-articular injection of canine adiposederived mesenchymal stem cells: an in vivo imaging and migration study. J Ocul Pharmacol Ther 28:307-317.
9. Zimmermann K, A Haas and A Oxenius. (2012). Systemic antibody responses to gut microbes in health and disease. Gut Microbes 3:42-47.
10. Costello EK, K Stagaman, L Dethlefsen, BJ Bohannan and DA Relman. (2012). The application of ecological theory toward an understanding of the human microbiome. Science 336:1255-1262.
11. Hooper LV, DR Littman and AJ Macpherson. (2012). Interactions between the microbiota and the immune system. Science 336:1268-1273.
12. Kamada N, SU Seo, GY Chen and G Nunez. (2013). Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol 13:321-335.
13. Ng KM, JA Ferreyra, SK Higginbottom, JB Lynch, PC Kashyap, S Gopinath, N Naidu, B Choudhury, BC Weimer, DM Monack and JL Sonnenburg. (2013). Microbiotaliberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 502:96-99.
14. Tsai KL, LA Clark and KE Murphy. (2007). Understanding hereditary diseases using the dog and human as companion model systems. Mamm Genome 18:444-451.
15. Krasnodembskaya A, G Samarani, Y Song, H Zhuo, X Su, JW Lee, N Gupta, M Petrini and MA Matthay. (2012). Human mesenchymal stem cells reduce mortality and bacteremia in gram-negative sepsis in mice in part by enhancing the phagocytic activity of blood monocytes. Am J Physiol Lung Cell Mol Physiol 302:L1003-L1013.
16. Mei SH, JJ Haitsma, CC Dos Santos, Y Deng, PF Lai, AS Slutsky, WC Liles and DJ Stewart. (2010). Mesenchymal stem cells reduce inflammation while enhancing bacterial clearance and improving survival in sepsis. Am J Respir Crit Care Med 182:1047-1057.
17. Lee JW, A Krasnodembskaya, DH McKenna, Y Song, J Abbott and MA Matthay. (2013). Therapeutic effects of human mesenchymal stem cells in ex vivo human lungs injured with live bacteria. Am J Respir Crit Care Med 187:751-760.
18. Delarosa O, W Dalemans and E Lombardo. (2012). Tolllike receptors as modulators of mesenchymal stem cells. Front Immunol 3:182.
19. Kim HS, TH Shin, SR Yang, MS Seo, DJ Kim, SK Kang, JH Park and KS Kang. (2010). Implication of NOD1 and NOD2 for the differentiation of multipotent mesenchymal stem cells derived from human umbilical cord blood. PLoS One 5:e15369.
20. Liotta F, R Angeli, L Cosmi, L Fili, C Manuelli, F Frosali, B Mazzinghi, L Maggi, A Pasini, et al. (2008). Toll-like receptors 3 and 4 are expressed by human bone marrowderived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26:279-289.
21. Raicevic G, M Najar, K Pieters, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2012). Inflammation and Toll-like receptor ligation differentially affect the osteogenic potential of human mesenchymal stromal cells depending on their tissue origin. Tissue Eng Part A 18: 1410-1418.
22. Tomchuck SL, KJ Zwezdaryk, SB Coffelt, RS Waterman, ES Danka and AB Scandurro. (2008). Toll-like receptors on human mesenchymal stem cells drive their migration and immunomodulating responses. Stem Cells 26:99-107.
23. Waterman RS, SL Tomchuck, SL Henkle and AM Betancourt. (2010). A new mesenchymal stem cell (MSC) paradigm: polarization into a pro-inflammatory MSC1 or an Immunosuppressive MSC2 phenotype. PLoS One 5: e10088.
24. Pevsner-Fischer M, V Morad, M Cohen-Sfady, L Rousso-Noori, A Zanin-Zhorov, S Cohen, IR Cohen and D Zipori. (2007). Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432.
25. Fiedler T, A Salamon, S Adam, N Herzmann, J Taubenheim and K Peters. (2013). Impact of bacteria and bacterial components on osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Exp Cell Res 319:2883-2892.
26. Anton K, D Banerjee and J Glod. (2012). Macrophageassociated mesenchymal stem cells assume an activated, migratory, pro-inflammatory phenotype with increased IL- 6 and CXCL10 secretion. PLoS One 7:e35036.
27. Lei JX, Z Wang, DY Hui, WH Yu, DH Zhou, WJ Xia, C Chen, QZ Zhang, ZC Wang, Q Zhang and ADP Xiang. (2011). Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity. Cell Immunol 271:147-156.
28. Miettinen JA, M Pietila, RJ Salonen, S Ohlmeier, K Ylitalo, HV Huikuri and P Lehenkari. (2011). Tumor necrosis factor alpha promotes the expression of immunosuppressive proteins and enhances the cell growth in a human bone marrow-derived stem cell culture. Exp Cell Res 317:791-801.
29. Bernardo ME and WE Fibbe. (2013). Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 13:392-402.
30. Chung DJ, K Hayashi, CA Toupadakis, A Wong and CE Yellowley. (2012). Osteogenic proliferation and differentiation of canine bone marrow and adipose tissue derived mesenchymal stromal cells and the influence of hypoxia. Res Vet Sci 92:66-75.
31. Elsinghorst EA. (1994). Measurement of invasion by gentamicin resistance. Methods Enzymol 236:405-420.
32. Ziemer CJ and SR Steadham. (2003). Evaluation of the specificity of Salmonella PCR primers using various intestinal bacterial species. Lett Appl Microbiol 37:463-469.
33. Fukushima H, Y Tsunomori and R Seki. (2003). Duplex real-time SYBR green PCR assays for detection of 17 species of food- or waterborne pathogens in stools. J Clin Microbiol 41:5134-5146.
34. Chen Y, N Kumar and N Siddique. (2011). Development and evaluation of a real-time polymerase chain reaction assay targeting iap for the detection of listeria monocytogenes in select food matrices. Foodborne Pathog Dis 8:1063-1069.
35. Ivanova P, S Peykov, A Dimitrova and SG Dimov. (2008). Molecular typing by genus-specific PCR and RAPD profiling of diverse Lactobacillus delbrueckii strains isolated from cow, sheep and buffalo yoghurts. Biotechnol Biotec Eq 22:748-753.
36. Klijn N, AH Weerkamp and WM Devos. (1995). Detection and characterization of lactose-utilizing Lactococcus Spp in natural ecosystems. Appl Environ Microb 61:788-792.
37. Junick J and M Blaut. (2012). Quantification of human fecal bifidobacterium species by use of quantitative realtime PCR analysis targeting the groEL gene. Appl Environ Microb 78:2613-2622.
38. Kiczak L, U Paslawska, J Bania, M Ugorski, I Sambor, A Kochman, J Blach and A Chelmonsia-Soyta. (2008). Increased expression of interleukin-1beta and its novel splice variant in canine hearts with volume overload. Cytokine 44:352-360.
39. de Bruin T, H de Rooster, H van Bree and, E Cox. (2005). Interleukin-8 mRNA expression in synovial fluid of canine stifle joints with osteoarthritis. Vet Immunol Immunopathol 108:387-397.
40. Tang JB, Y Xu, F Ding and XT Wang. (2003). Tendon healing in vitro: promotion of collagen gene expression by bFGF with NF-kappaB gene activation. J Hand Surg 28:215-220.
41. Livak KJ and TD Schmittgen. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408.
42. Wunderli PS and PJ Felsburg. (1989). An improved method for the isolation of enriched canine peripheral blood mononuclear cell and peripheral blood lymphocyte preparations. Vet Immunol Immunopathol 20:335-344.
43. Monack DM, B Raupach, AE Hromockyj and S Falkow. (1996). Salmonella typhimurium invasion induces apoptosis in infected macrophages. Proc Natl Acad Sci U S A 93:9833-9838.
44. He X, DO Mishchuk, J Shah, BC Weimer and CM Slupsky. (2013). Cross-talk between E. coli strains and a human colorectal adenocarcinoma-derived cell line. Sci Rep 3:3416.
45. Francois M, R Romieu-Mourez, S Stock-Martineau, MN Boivin, JL Bramson and J Galipeau. (2009). Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties. Blood 114:2632-2638.
46. Romieu-Mourez R, M Francois, MN Boivin, J Stagg and J Galipeau. (2007). Regulation of MHC class II expression and antigen processing in murine and human mesenchymal stromal cells by IFN-gamma, TGF-beta, and cell density. J Immunol 179:1549-1558.
47. Chang J, F Liu, M Lee, B Wu, K Ting, JN Zara, C Soo, K Al Hezaimi, W Zou, et al. (2013). NF-kappaB inhibits osteogenic differentiation of mesenchymal stem cells by promoting beta-catenin degradation. Proc Natl Acad Sci U S A 110:9469-9474.
48. Liu X, X Qu, Y Chen, L Liao, K Cheng, C Shao, M Zenke, A Keating and RC Zhao. (2012). Mesenchymal stem/stromal cells induce the generation of novel IL-10-dependent regulatory dendritic cells by SOCS3 activation. J Immunol 189:1182-1192.
49. Takada I, AP Kouzmenko and S Kato. (2010). PPARgamma Signaling Crosstalk in Mesenchymal Stem Cells. PPAR Res 2010:341671.
50. Kubiczkova L, L Sedlarikova, R Hajek and S Sevcikova. (2012). TGF-beta-an excellent servant but a bad master. J Transl Med 10:183.
51. Bai L, DP Lennon, AI Caplan, A DeChant, J Hecker, J Kranso, A Zaremba and RH Miller. (2012). Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models. Nat Neurosci 15:862-870.
52. Kim JM, L Eckmann, TC Savidge, DC Lowe, T Witthoft and MF Kagnoff. (1998). Apoptosis of human intestinal epithelial cells after bacterial invasion. J Clin Invest 102: 1815-1823.
53. Kiama SG, D Dreher, L Cochand, M Kok, C Obregon, L Nicod and P Gehr. (2006). Host cell responses of Salmonella typhimurium infected human dendritic cells. Immunol Cell Biol 84:475-481.
54. Zhang X, JE Aubin, TH Kim, U Payne, B Chiu and RD Inman. (2004). Synovial fibroblasts infected with Salmonella enterica serovar Typhimurium mediate osteoclast differentiation and activation. Infect Immun 72:7183-7189.
55. Liang L, C Dong, X Chen, Z Fang, J Xu, M Liu, X Zhang, DS Gu, D Wang, et al. (2011). Human umbilical cord mesenchymal stem cells ameliorate mice trinitrobenzene sulfonic acid (TNBS)-induced colitis. Cell Transplant 20:1395-1408.
56. Li H, Y Jiang, X Jiang, X Guo, H Ning, Y Li, L Liao, H Yao, X Wang, et al. (2014). CCR7 guides migration of mesenchymal stem cell to secondary lymphoid organs: a novel approach to separate GvHD from GvL effect. Stem Cells. DOI: 10.1002/stem.1656.
57. Lebeer S, J Vanderleyden and SC De Keersmaecker. (2010). Host interactions of probiotic bacterial surface molecules: comparison with commensals and pathogens. Nat Rev Microbiol 8:171-184.
58. Stagg J, S Pommey, N Eliopoulos and J Galipeau. (2006). Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 107:2570-2577.
59. Chan JL, KC Tang, AP Patel, LM Bonilla, N Pierobon, NM Ponzio and P Rameshwar. (2006). Antigen-presenting property of mesenchymal stem cells occurs during a narrow window at low levels of interferon-gamma. Blood 107: 4817-4824.
60. Raicevic G, R Rouas, M Najar, P Stordeur, HI Boufker, D Bron, P Martiat, M Goldman, MT Nevessignsky and L Lagneaux. (2010). Inflammation modifies the pattern and the function of Toll-like receptors expressed by human mesenchymal stromal cells. Hum Immunol 71:235-244.
61. Opitz CA, UM Litzenburger, C Lutz, TV Lanz, I Tritschler, A Koppel, E Tolosa, M Hoberg, J Anderl, et al. (2009). Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R. Stem Cells 27:909-919.
62. Kalinski P. (2012). Regulation of immune responses by prostaglandin E2. J Immunol 188:21-28.
63. Heusinkveld M, PJ de Vos van Steenwijk, R Goedemans, TH Ramwadhdoebe, A Gorter, MJ Welters, T van Hall and SH van der Burg. (2011). M2 macrophages induced by prostaglandin E2 and IL-6 from cervical carcinoma are switched to activated M1 macrophages by CD4 + Th1 cells. J Immunol 187:1157-1165.
64. Chen K, D Wang, WT Du, ZB Han, H Ren, Y Chi, SG Yang, D Zhu, F Bayard and ZC Han. (2010). Human umbilical cord mesenchymal stem cells hUC-MSCs exert immunosuppressive activities through a PGE2-dependent mechanism. Clin Immunol 135:448-458.
65. Solchaga LA and EA Zale. (2012). Prostaglandin E2: a putative potency indicator of the immunosuppressive activity of human mesenchymal stem cells. Am J Stem Cells 1:138-145.
66. Ohh M and F Takei. (1996). New insights into the regulation of ICAM-1 gene expression. Leuk Lymphoma 20:223-228.
67. Najar M, G Raicevic, H Id Boufker, B Stamatopoulos, C De Bruyn, N Meuleman, D Bron, M Toungouz and L Lagneaux. (2010). Modulated expression of adhesion molecules and galectin-1: role during mesenchymal stromal cell immunoregulatory functions. Exp Hematol 38:922-932.
68. Carrade DD and DL Borjesson. (2013). Immunomodulation by mesenchymal stem cells in veterinary species. Comp Med 63:207-217.
69. Lotfinegad P, K Shamsasenjan, A Movassaghpour, J Majidi and B Baradaran. (2014). Immunomodulatory nature and site specific affinity of mesenchymal stem cells: a hope in cell therapy. Adv Pharm Bull 4:5-13.